RXO (NYSE:RXO) Sets New 12-Month Low Following Analyst Downgrade

RXO, Inc. (NYSE:RXOGet Free Report)’s stock price reached a new 52-week low on Wednesday after The Goldman Sachs Group lowered their price target on the stock from $24.00 to $21.00. The Goldman Sachs Group currently has a neutral rating on the stock. RXO traded as low as $12.75 and last traded at $12.89, with a volume of 2093105 shares trading hands. The stock had previously closed at $14.21.

Several other equities research analysts also recently weighed in on RXO. Barclays decreased their price target on shares of RXO from $24.00 to $22.00 and set an “overweight” rating for the company in a research note on Wednesday, April 2nd. Deutsche Bank Aktiengesellschaft initiated coverage on RXO in a research note on Friday, March 7th. They issued a “hold” rating and a $19.00 target price for the company. Oppenheimer downgraded RXO from an “outperform” rating to a “market perform” rating in a research note on Friday, April 4th. Susquehanna cut their price target on RXO from $18.00 to $13.00 and set a “negative” rating on the stock in a report on Wednesday, March 26th. Finally, Jefferies Financial Group decreased their price objective on RXO from $33.00 to $30.00 and set a “buy” rating for the company in a report on Friday, January 10th. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $23.40.

Check Out Our Latest Stock Analysis on RXO

Institutional Trading of RXO

Several institutional investors have recently made changes to their positions in the company. Blue Trust Inc. lifted its position in shares of RXO by 79.7% during the fourth quarter. Blue Trust Inc. now owns 1,150 shares of the company’s stock valued at $27,000 after purchasing an additional 510 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in RXO in the 3rd quarter valued at about $28,000. Smartleaf Asset Management LLC increased its stake in RXO by 228.4% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company’s stock valued at $30,000 after buying an additional 868 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its position in shares of RXO by 68.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock worth $39,000 after buying an additional 570 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. boosted its stake in shares of RXO by 407.0% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company’s stock worth $43,000 after buying an additional 1,445 shares during the last quarter. Institutional investors own 92.73% of the company’s stock.

RXO Trading Down 6.3 %

The company has a debt-to-equity ratio of 0.22, a current ratio of 1.26 and a quick ratio of 1.33. The company has a market capitalization of $2.29 billion, a P/E ratio of -6.60, a price-to-earnings-growth ratio of 4.55 and a beta of 1.60. The firm has a fifty day moving average price of $19.07 and a 200-day moving average price of $24.39.

RXO (NYSE:RXOGet Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.06. RXO had a positive return on equity of 1.53% and a negative net margin of 6.26%. On average, equities research analysts anticipate that RXO, Inc. will post 0.31 earnings per share for the current year.

About RXO

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Further Reading

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.